Construct Design ![decoration1](https://static.igem.org/mediawiki/2018/3/3a/T--TecMonterrey_GDL--decoration1.png)
Composite part Plan A:
![](https://static.igem.org/mediawiki/2018/b/bf/T--TecMonterrey_GDL--ConstructEColi.png)
![](https://static.igem.org/mediawiki/2018/9/91/T--TecMonterrey_GDL--ConstructIL-6.png)
![](https://static.igem.org/mediawiki/2018/f/f1/T--TecMonterrey_GDL--Construct3.png)
![](https://static.igem.org/mediawiki/2018/e/ea/T--TecMonterrey_GDL--Construct4.png)
References: [1] Müller-Newen, G., Küster, A., Hemmann, U., Keul,R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., Heinrich, P. (1998) Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses. The Journal American of Association Immunology. ISSN: 1550-6606. [2] Han,S., Machhi, S., Berge,H., Xi, G., Linke, T., and Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express. Doi: https://doi.org/10.1186/s13568-017-0394-1
Composite part Plan B (E. coli BL21):
![](https://static.igem.org/mediawiki/2018/9/91/T--TecMonterrey_GDL--ConstructIL-6.png)
![](https://static.igem.org/mediawiki/2018/b/bf/T--TecMonterrey_GDL--ConstructEColi.png)
![](https://static.igem.org/mediawiki/2018/f/f1/T--TecMonterrey_GDL--Construct3.png)